A detailed history of Exodus Point Capital Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 2,786 shares of AMGN stock, worth $740,936. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,786
Holding current value
$740,936
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $861,932 - $939,940
2,786 New
2,786 $898,000
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $5.53 Million - $6.53 Million
25,788 New
25,788 $5.73 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $2.77 Million - $3.52 Million
12,095 New
12,095 $3.18 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $12.6 Million - $14.2 Million
-56,012 Closed
0 $0
Q2 2022

Aug 19, 2022

BUY
$230.71 - $256.74 $9.66 Million - $10.7 Million
41,865 Added 295.93%
56,012 $13.6 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $3.1 Million - $3.43 Million
14,147 New
14,147 $3.42 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $3.65 Million - $4.17 Million
-18,338 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $2.78 Million - $3.25 Million
13,085 Added 249.1%
18,338 $3.9 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $1.23 Million - $1.36 Million
5,253 New
5,253 $1.28 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $2.6 Million - $3.1 Million
-12,036 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $2.82 Million - $3.14 Million
12,036 New
12,036 $3.06 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $261,702 - $321,145
-1,323 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $241,103 - $319,769
1,323 New
1,323 $268,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $7.32 Million - $9.41 Million
-38,692 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $6.74 Million - $8.07 Million
38,692 New
38,692 $7.49 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $142B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.